Public source
Reviewed 19 Aug 2026
Completeness Good (47%)
aview:RT ACS conducts automatic segmentation of normal organs using deep learning AI technology
No papers to support — we monitor for new evidence.
Key features
Autosegmentation of OAR
General Information
Product name
Company
Workflow phase
Modality
Treatment site
Exact structures
Regulatory Information
Pathway:
MDR
Class:
Class IIb
Not verified by Health AI Register
Verified by Health AI Register
Other certifications
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Prerequisites
Not specified
Defined prerequisite(s)
Not specified
Treatment technique
Delivery system
Workflow features
Patient population age
Input
Input format
Output
Not specified
Output format
Integration
Not specified
Integration method
Not specified
API documentation availability
Not specified
API documentation, if publicly available
Not specified
TPS compatibility
Deployment
Not specified
Trigger for AI functionality
Processing time
Not specified
Retraining locally
Claims
Not specified
Known limitations
Not specified
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Public | First published: Jul 6, 2026 | Last updated: Aug 19, 2026